Major developments for three Swiss Medtech startups

Event date: 15.10.2026

Following CE marking for NOAH, OxyPrem is now preparing for commercialisation across Europe. NeuroLF by Positrigo has become the first dedicated brain PET system to achieve EARL accreditation, which promotes the harmonisation and standardisation of PET imaging across centres in Europe.

Full article via Startupticker Beitrag

zurück